Sun, C., Lu, B., Liu, Y., Zhang, Y., Wei, H., Hu, X., . . . Cheng, R. (2021). Reduced Effectiveness and Comparable Safety in Biweekly vs. Weekly PEGylated Recombinant Human Growth Hormone for Children With Growth Hormone Deficiency: A Phase IV Non-Inferiority Threshold Targeted Trial. Frontiers Media S.A.
Cita Chicago Style (17a ed.)Sun, Chengjun, et al. Reduced Effectiveness and Comparable Safety in Biweekly Vs. Weekly PEGylated Recombinant Human Growth Hormone for Children With Growth Hormone Deficiency: A Phase IV Non-Inferiority Threshold Targeted Trial. Frontiers Media S.A, 2021.
Cita MLA (8a ed.)Sun, Chengjun, et al. Reduced Effectiveness and Comparable Safety in Biweekly Vs. Weekly PEGylated Recombinant Human Growth Hormone for Children With Growth Hormone Deficiency: A Phase IV Non-Inferiority Threshold Targeted Trial. Frontiers Media S.A, 2021.